{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:04:40Z","timestamp":1788599080895,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00406-020-01158-3","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T05:02:52Z","timestamp":1593838972000},"page":"775-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic risks of schizophrenia identified in a matched case\u2013control study"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0132-7270","authenticated-orcid":false,"given":"Kengo","family":"Oishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomihisa","family":"Niitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Kanahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Iwayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Toyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"1158_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","volume":"81","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R, Owen MJ, Murray R (2017) The role of genes, stress and dopamine in the development of schizophrenia. Biol Psychiatry 81:9\u201320","journal-title":"Biol Psychiatry"},{"key":"1158_CR2","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","volume":"2","author":"S Saha","year":"2005","unstructured":"Saha S, Chant D, Welham J, McGrath J (2005) A systematic review of the prevalence of schizophrenia. PLoS Med 2:e141","journal-title":"PLoS Med"},{"key":"1158_CR3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/mp.2017.151","volume":"11","author":"VL Nimgaonkar","year":"2017","unstructured":"Nimgaonkar VL, Prasad KM, Chowdari KV, Severance EG, Yolken RH (2017) The complement system: A gateway to gene-environment interactions in schizophrenia pathogenesis. Mol Psychiatry 11:1554\u20131561. https:\/\/doi.org\/10.1038\/mp.2017.151","journal-title":"Mol Psychiatry"},{"key":"1158_CR4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.biopsych.2017.08.017","volume":"83","author":"R Hilker","year":"2018","unstructured":"Hilker R, Helenius D, Fagerlund B et al (2018) Heritability of schizophrenia and schizophrenia spectrum based on the nationwide Danish Twin Register. Biol Psychiatry 83:492\u2013498. https:\/\/doi.org\/10.1016\/j.biopsych.2017.08.017","journal-title":"Biol Psychiatry"},{"key":"1158_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.4088\/JCP.09m05785yel","volume":"72","author":"O Agid","year":"2011","unstructured":"Agid O, Arenovich T, Sajeev G et al (2011) An algorithm-based approach to first-episode schizophrenia: Response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry 72:1439\u20131444","journal-title":"J Clin Psychiatry"},{"key":"1158_CR6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00127-013-0700-4","volume":"48","author":"H H\u00e4fner","year":"2013","unstructured":"H\u00e4fner H, Maurer K, an der Heiden W (2013) ABC Schizophrenia study: an overview of results since 1996. Soc Psychiatry Psychiatr Epidemiol 48:1021\u20131031. https:\/\/doi.org\/10.1007\/s00127-013-0700-4","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"1158_CR7","first-page":"37","volume":"1","author":"R Li","year":"2016","unstructured":"Li R, Ma X, Wang G, Yang J, Wang C (2016) Why sex differences in schizophrenia? J Transl Neurosci (Beijing) 1:37\u201342","journal-title":"J Transl Neurosci (Beijing)"},{"key":"1158_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.10.037","author":"S Mistry","year":"2017","unstructured":"Mistry S, Harrison JR, Smith DJ, Escott-Price V, Zammit S (2017) The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: systematic review. Schizophr Res. https:\/\/doi.org\/10.1016\/j.schres.2017.10.037","journal-title":"Schizophr Res"},{"key":"1158_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/ajmg.b.32159","volume":"162B","author":"JM Goldstein","year":"2013","unstructured":"Goldstein JM, Cherkerzian S, Tsuang MT, Petryshen TL (2013) Sex differences in the genetic risk for schizophrenia: History of the evidence for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet 162B:698\u2013710. https:\/\/doi.org\/10.1002\/ajmg.b.32159","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1158_CR10","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.2147\/NDT.S176455","volume":"14","author":"R Escamilla","year":"2018","unstructured":"Escamilla R, Camarena B, Saracco-Alvarez R, Fres\u00e1n A, Hern\u00e1ndez S, Aguilar-Garc\u00eda A (2018) Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia. Neuropsychiatr Dis Treat 14:2981\u20132987. https:\/\/doi.org\/10.2147\/NDT.S176455","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"128","key":"1158_CR11","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD (2012) Dopamine synthesis 127 capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry 169(128):1203\u20131210","journal-title":"Am J Psychiatry"},{"issue":"8","key":"1158_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.biopsych.2019.05.014","volume":"86","author":"EM Tunbridge","year":"2019","unstructured":"Tunbridge EM, Narajos M, Harrison CH, Beresford C, Cipriani A, Harrison PJ (2019) Which dopamine polymorphisms are functional? Systematic review and meta-analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2. Biol Psychiatry 86(8):608\u2013620","journal-title":"Biol Psychiatry"},{"key":"1158_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(78)91409-5","volume":"2","author":"G Chouinard","year":"1978","unstructured":"Chouinard G, Jones BD (1978) Schizophrenia as dopamine-deficiency disease. Lancet 2:99\u2013100 (PMID: 78321)","journal-title":"Lancet"},{"key":"1158_CR14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000477313","volume":"86","author":"G Chouinard","year":"2017","unstructured":"Chouinard G, Samaha AN, Chouinard VA, Peretti CS, Kanahara N, Takase M, Iyo M (2017) Antipsychotic-induced dopamine supersensitivity psychosis: Pharmacology, criteria, and therapy. Psychother Psychosom 86:189\u2013219. https:\/\/doi.org\/10.1159\/000477313","journal-title":"Psychother Psychosom"},{"key":"1158_CR15","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.18com12123","author":"JM Kane","year":"2019","unstructured":"Kane JM, Agid O, Baldwin ML et al (2019) Clinical guidance on the identification and management of treatment-resistant schizophrenia. J Clin Psychiatry. https:\/\/doi.org\/10.4088\/jcp.18com12123","journal-title":"J Clin Psychiatry"},{"key":"1158_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/JCP.0b013e31828ea95c","volume":"33","author":"M Iyo","year":"2013","unstructured":"Iyo M, Tadokoro S, Kanahara N et al (2013) Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis. J Clin Psychopharmacol 33:398\u2013404","journal-title":"J Clin Psychopharmacol"},{"key":"1158_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.schres.2017.03.014","volume":"190","author":"M Takase","year":"2017","unstructured":"Takase M, Kanahara N, Oda Y, Niitsu T, Watanabe H, Iyo M (2017) The impacts of dopamine D2 receptor polymorphism and antipsychotic dosage on dopamine supersensitivity psychosis in schizophrenia. Schizophr Res 190:182\u2013183","journal-title":"Schizophr Res"},{"issue":"e0207133","key":"1158_CR18","first-page":"18","volume":"13","author":"K Oishi","year":"2018","unstructured":"Oishi K, Kanahara N, Takase M et al (2018) Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia. PLoS One 13(e0207133):18","journal-title":"PLoS One"},{"key":"1158_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.schres.2019.08.021","volume":"215","author":"K Oishi","year":"2020","unstructured":"Oishi K, Iyo M, Niitsu T, Takase M, Sato Y, Kanahara N (2020) Genetic combination risk for schizophrenia. Schizophr Res 215:473\u2013474. https:\/\/doi.org\/10.1016\/j.schres.2019.08.021","journal-title":"Schizophr Res"},{"key":"1158_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/pcn.12157","volume":"68","author":"M Horiguchi","year":"2014","unstructured":"Horiguchi M, Ohi K, Hashimoto R et al (2014) Functional polymorphism (C-824T) of the tyrosine hydroxylase gene affects IQ in schizophrenia. Psychiatry Clin Neurosci 68:456\u2013462. https:\/\/doi.org\/10.1111\/pcn.12157","journal-title":"Psychiatry Clin Neurosci"},{"key":"1158_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","volume":"39","author":"RM Weinshilboum","year":"1999","unstructured":"Weinshilboum RM, Otterness DM, Szumlanski C (1999) Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 39:19\u201352. https:\/\/doi.org\/10.1146\/annurev.pharmtox.39.1.19","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1158_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.mp.4000350","volume":"3","author":"T Pohjalainen","year":"1998","unstructured":"Pohjalainen T, Rinne JO, N\u00e5gren K et al (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256\u2013260","journal-title":"Mol Psychiatry"},{"key":"1158_CR23","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/ije\/dyu038","volume":"43","author":"Z Steel","year":"2014","unstructured":"Steel Z, Marnane C, Iranpour C et al (2014) The global prevalence of common mental disorders: a systematic review and meta-analysis 1980\u20132013. Int J Epidemiol 43:476\u2013493","journal-title":"Int J Epidemiol"},{"key":"1158_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/YCO.0b013e32816ebc8c","volume":"20","author":"RC Kessler","year":"2007","unstructured":"Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustun TB (2007) Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry 20:359\u2013364. https:\/\/doi.org\/10.1097\/YCO.0b013e32816ebc8c","journal-title":"Curr Opin Psychiatry"},{"key":"1158_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ajhg.2008.08.019","volume":"83","author":"Y Yamaguchi-Kabata","year":"2008","unstructured":"Yamaguchi-Kabata Y, Nakazono K, Takahashi A et al (2008) Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 83:445\u2013456. https:\/\/doi.org\/10.1016\/j.ajhg.2008.08.019","journal-title":"Am J Hum Genet"},{"key":"1158_CR26","doi-asserted-by":"publisher","first-page":"e20468","DOI":"10.1371\/journal.pone.0020468","volume":"6","author":"K Yamada","year":"2011","unstructured":"Yamada K, Iwayama K, Hattori E et al (2011) Genome-wide association study of schizophrenia in Japanese population. PLoS One 6:e20468","journal-title":"PLoS One"},{"key":"1158_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ajmg.b.30147","volume":"134B","author":"ML Hoogendoorn","year":"2005","unstructured":"Hoogendoorn ML, Bakker SC, Schnack HG et al (2005) No association between 12 dopaminergic genes and schizophrenia in a large Dutch sample. Am J Med Genet B Neuropsychiatr Genet 134B:6\u20139","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1158_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12017-016-8392-z","volume":"18","author":"TB Gonz\u00e1lez-Castro","year":"2016","unstructured":"Gonz\u00e1lez-Castro TB, Hern\u00e1ndez-D\u00edaz Y, Ju\u00e1rez-Rojop IE, L\u00f3pez-Narv\u00e1ez ML, Tovilla-Z\u00e1rate CA, Fresan A (2016) The role of a catechol-O-methyltransferase (COMT) Val158Met genetic polymorphism in schizophrenia: a systematic review and updated meta-analysis on 32,816 subjects. Neuromol Med 18:216\u2013231","journal-title":"Neuromol Med"},{"key":"1158_CR29","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/S1734-1140(13)71476-2","volume":"65","author":"J Pelka-Wysiecka","year":"2013","unstructured":"Pelka-Wysiecka J, Wronski M, Jasiewicz A et al (2013) BDNF rs 6265 polymorphism and COMT rs 4680 polymorphism in deficit schizophrenia in Polish sample. Pharmacol Rep 65:1185\u20131193","journal-title":"Pharmacol Rep"},{"key":"1158_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.b.32281.Review","volume":"168B","author":"J Yao","year":"2015","unstructured":"Yao J, Pan YQ, Ding M, Pang H, Wang BJ (2015) Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 168B:1\u201313. https:\/\/doi.org\/10.1002\/ajmg.b.32281.Review","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"1158_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12993-016-0114-z","volume":"12","author":"TB Gonz\u00e1lez-Castro","year":"2016","unstructured":"Gonz\u00e1lez-Castro TB, Hern\u00e1ndez-D\u00edaz Y, Ju\u00e1rez-Rojop IE et al (2016) The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis. Behav Brain Funct 12:29","journal-title":"Behav Brain Funct"},{"key":"1158_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01213011-200506000-00003","volume":"15","author":"A Laakso","year":"2005","unstructured":"Laakso A, Pohjalainen T, Bergman J et al (2005) The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal l-amino acid decarboxylase in healthy subjects. Pharmacogenet Genom 15:387\u2013391","journal-title":"Pharmacogenet Genom"},{"key":"1158_CR33","doi-asserted-by":"publisher","first-page":"10196","DOI":"10.1523\/JNEUROSCI.0665-07.2007","volume":"27","author":"L Yavich","year":"2007","unstructured":"Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, M\u00e4nnist\u00f6 PT (2007) Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. J Neurosci 27:10196\u201310209","journal-title":"J Neurosci"},{"key":"1158_CR34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/sj.npp.1300218","volume":"28","author":"M Matsumoto","year":"2003","unstructured":"Matsumoto M, Weickert CS, Beltaifa S et al (2003) Catechol O-methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 28:1521\u20131530","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1158_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41398-019-0532-4","volume":"9","author":"C Liu","year":"2019","unstructured":"Liu C, Kanazawa T, Tian Y, Mohamed Saini S, Mancuso S et al (2019) The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies. Transl Psychiatry 9(1):205. https:\/\/doi.org\/10.1038\/s41398-019-0532-4","journal-title":"Transl Psychiatry"},{"key":"1158_CR36","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1007\/s12035-017-0708-y","volume":"55","author":"B Misiak","year":"2018","unstructured":"Misiak B, Stramecki F, Gaw\u0119da \u0141, Prochwicz K, S\u0105siadek MM, Moustafa AA et al (2018) Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: a systematic review. Mol Neurobiol 55:5075\u20135100. https:\/\/doi.org\/10.1007\/s12035-017-0708-y","journal-title":"Mol Neurobiol"},{"key":"1158_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2217\/epi-2016-0106","volume":"9","author":"B Swathy","year":"2017","unstructured":"Swathy B, Banerjee M (2017) Understanding epigenetics of schizophrenia in the backdrop of its antipsychotic drug therapy. Epigenomics 9:721\u2013736","journal-title":"Epigenomics"},{"key":"1158_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.eurpsy.2016.09.003","volume":"40","author":"P Fusar-Poli","year":"2017","unstructured":"Fusar-Poli P, Tantardini M, De Simone S et al (2017) Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk. Eur Psychiatry 40:65\u201375","journal-title":"Eur Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-020-01158-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-020-01158-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T19:19:07Z","timestamp":1625339947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-020-01158-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1007\/s00406-020-01158-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/702100","asserted-by":"object"}]},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"9 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have no conflicts of interests to disclose and approved this submission.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committees of Chiba University (Seimei 900), RIKEN (Wako1 15-3), and all participating institutes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave informed, written consent to join the study after receiving a full explanation of study protocols and objectives.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants gave informed, written consent for publication after receiving a full explanation of study protocols and objectives.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}